Research and Markets: Global Orphan Diseases Pipeline 2014-2017

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/czrhcw/orphan_diseases) has announced the addition of the "Orphan Diseases Pipeline Highlights - 2014 Update" report to their offering.

The latest report Orphan Diseases Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Orphan Diseases market. It covers emerging therapies for Orphan Diseases in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages: The report provides Orphan Diseases pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes: The report provides Orphan Diseases pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

By Indication: The report provides Orphan Diseases pipeline moleculesby Indication. This helps executives categorize pipeline by the disease.

Company: The report provides Orphan Diseases pipeline molecules by the Originator Company.

Short-term Launch Highlights: Find out which Orphan Diseases pipeline products will be launched in the US and Ex-US till 2017.

SUMMARY:

- Orphan Diseases phase 3 clinical trial pipeline molecules

- Orphan Diseases phase 2 clinical trial pipeline molecules

- Orphan Diseases phase 1 clinical trial pipeline molecules

- Orphan Diseases preclinical research pipeline molecules

- Orphan Diseases discovery stage pipeline molecules

- Orphan Diseases pipeline molecules short-term launch highlights

For more information visit http://www.researchandmarkets.com/research/czrhcw/orphan_diseases

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals